North America Infectious Disease Diagnostics Market Forecast to 2028

Report Code : BMIRE00025326 | Region : North America | Industry : Biotechnology | Published Date : 12/Jul/2022
North America Infectious Disease Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Microbiology, and Others), Testing Type (Laboratory Testing and Point of Care Testing), Disease Indication (HIV, Hepatitis, Healthcare-Associated Infections, Human Papillomavirus, Tuberculosis, Influenza, and Others), and End User (Hospitals and Clinics, Pathology/Diagnostic Laboratories, Research Institutes, Home Care Settings, and Others)

The North America infectious disease diagnostics market is expected to grow from US$ 8,921.15 million in 2021 to US$ 14,296.46 million by 2028; it is estimated to grow a CAGR of 7.0% from 2021 to 2028.

Infectious diseases are caused by infectious agents, including viruses, bacteria, parasites, fungi, and toxic products. HIV is a major public health problem across the region. As per the Joint United Nations Programme on HIV/AIDS (UNAIDS), ~37.7 million people had HIV in 2020, and out of these—1.7 million were children aged 0–14 years, 36 million were adults, and over half (53%) were girls and women. Furthermore, 1.5 million new HIV cases were reported in 2020. Similarly, hepatitis, inflammation of the liver, is caused by a viral infection. The five primary strains of hepatitis viruses are A, B, C, D, and E. As per World Health Organization (WHO), ~58 million people have chronic hepatitis C virus infection, while ~1.5 million new infections occur annually. According to WHO, tuberculosis (TB) is the thirteenth-leading cause of death and the second leading infectious disease after COVID-19. SARS-CoV-2 is a novel coronavirus that causes COVID-19. The COVID-19 outbreak is straining healthcare systems, increasing the need to develop diagnostic devices and service centers. Moreover, hospital-acquired infections or healthcare-associated infections (HAIs) have high morbidity and mortality rate. Also, such infections cost the healthcare system billions of dollars every year. Diagnostics play a vital role in determining the direction of any medical treatment of infectious diseases. Thus, the rising prevalence of infectious diseases propels the growth of the infectious disease diagnostics market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America infectious disease diagnostics market at a notable CAGR during the forecast period.

North America Infectious Disease Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

North America Infectious Disease Diagnostics Market Segmentation

The North America infectious disease diagnostics market is segmented into product, technology, testing type, disease indication, end user, and country. Based on product, the North America infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment led the market in 2020; however, the software & services segment is likely to register the highest CAGR during the forecast period. Based on technology, the market is categorized into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. The next generation sequencing segment dominated the market in 2020, and it is expected to register the highest CAGR during the forecast period. Based on testing type, the market is divided into laboratory testing and point of care testing. The laboratory testing segment led the market in 2020; however, the point of care testing segment is likely to register a higher CAGR during the forecast period. Based on disease indication, the market is segmented into HIV, hepatitis, healthcare-associated infections, human papillomavirus, tuberculosis, influenza, and others. The hepatitis segment dominated the market in 2020; however, the healthcare-associated infections segment is expected to register the highest CAGR during the forecast period. Based on end user, the North America infectious disease diagnostics market is segmented into hospitals and clinics, pathology/diagnostic laboratories, research institutes, home care settings, and others. The pathology/diagnostic laboratories segment dominated the market in 2020; however, the home care settings segment is likely to register the highest CAGR during the forecast period. Based on country, the North America infectious disease diagnostics market is segmented into the US, Canada, and Mexico.

Abbott; AccuBioTech Co., Ltd.; ACON Laboratories, Inc.; BD; bioMerieux SA; BIO-RAD LABORATORIES INC.; Cardinal Health Inc; Danaher; F. HOFFMANN-LA ROCHE LTD.; and Trinity Biotechare are among the leading companies operating in the North America infectious disease diagnostics market.

The List of Companies - North America Infectious Disease Diagnostics Market

● Abbott

● AccuBioTech Co., Ltd.

● ACON Laboratories, Inc.

● BD

● bioMerieux SA

● BIO-RAD LABORATORIES INC.

● Cardinal Health Inc

● Danaher

● F. HOFFMANN-LA ROCHE LTD.

● Trinity Biotech

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Infectious Disease Diagnostics Market – By Product

1.3.2 North America Infectious Disease Diagnostics Market – By Technology

1.3.3 North America Infectious Disease Diagnostics Market – By Testing Type

1.3.4 North America Infectious Disease Diagnostics Market – By Disease Indication

1.3.5 North America Infectious Disease Diagnostics Market – By End User

1.3.6 North America Infectious Disease Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Infectious Disease Diagnostics Market Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Experts Opinion

5. North America Infectious Disease Diagnostics Market Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Infectious Diseases

5.1.2 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Growing Opportunities in Developing Nations

5.4 Future Trend

5.4.1 Rising Number of Product Approvals and Launches

5.5 Impact Analysis

6. Infectious Disease Diagnostics Market– North America Analysis

6.1 North America Infectious Disease Diagnostics Market Revenue Forecast and Analysis

7. North America Infectious Disease Diagnostics Market Revenue and Forecast To 2028– by Product

7.1 Overview

7.2 North America by Product: Market Revenue and Forecast Analysis (US$ Million)

7.3 Kits and Reagents

7.3.1 Overview

7.3.2 Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments Market Revenue and Forecast to 2028 (US$ Million)

7.5 Software and Services

7.5.1 Overview

7.5.2 Software and Services Market Revenue and Forecast to 2028 (US$ Million)

8. North America Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Technology

8.1 North America Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)

8.2 Immunodiagnostics

8.2.1 Overview

8.2.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Polymerase Chain Reaction (PCR)

8.3.1 Overview

8.3.2 PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Next Generation Sequencing

8.4.1 Overview

8.4.2 Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Clinical Microbiology

8.5.1 Overview

8.5.2 Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Testing Type

9.1 North America Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)

9.2 Laboratory Testing

9.2.1 Overview

9.2.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Point of Care Testing

9.3.1 Overview

9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Disease Indication

10.1 Overview

10.2 North America Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)

10.3 HIV

10.3.1 Overview

10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)

10.4 Hepatitis

10.4.1 Overview

10.4.2 Hepatitis Market Revenue and Forecast to 2028 (US$ Million)

10.5 Healthcare Associated Infections (HAIs)

10.5.1 Overview

10.5.2 Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)

10.6 Human Papillomavirus (HPV)

10.6.1 Overview

10.6.2 Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)

10.7 Tuberculosis (TB)

10.7.1 Overview

10.7.2 Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)

10.8 Influenza

10.8.1 Overview

10.8.2 Influenza Market Revenue and Forecast to 2028 (US$ Million)

10.9 Others

10.9.1 Overview

10.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. North America Infectious Disease Diagnostics Market Analysis – by End User

11.1 Overview

11.2 North America Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)

11.3 Hospitals and Clinics

11.3.1 Overview

11.3.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.4 Pathology or Diagnostic Laboratories

11.4.1 Overview

11.4.2 Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.5 Research Institutes

11.5.1 Overview

11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.6 Home Care Settings

11.6.1 Overview

11.6.2 Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.7 Others

11.7.1 Overview

11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2028 – Country Analysis

12.1 North America: Infectious Disease Diagnostics Market

12.1.1 Overview

12.1.3 North America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.1.3.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3.1.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3.1.2 US: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.3.1.3 US: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.3.1.4 US: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.3.1.5 US: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.3.1.6 US: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.1.3.2 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3.2.1 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3.2.2 Canada: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.3.2.3 Canada: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.3.2.4 Canada: Infectious Disease Diagnostics Market, by Testing Type , 2019–2028 (US$ Million)

12.1.3.2.5 Canada: Infectious Disease Diagnostics Market, by Disease Indication , 2019–2028 (US$ Million)

12.1.3.2.6 Canada: Infectious Disease Diagnostics Market, by End User , 2019–2028 (US$ Million)

12.1.3.3 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3.3.1 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3.3.2 Mexico: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.3.3.3 Mexico: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.3.3.4 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.3.3.5 Mexico: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.3.3.6 Mexico: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 Danaher

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Abbott

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 BD

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Trinity Biotech

14.4.1 1.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 F. HOFFMANN-LA ROCHE LTD.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Cardinal Health Inc.

14.6.1 1.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 bioMerieux SA

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 BIO-RAD LABORATORIES INC.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 AccuBioTech Co., Ltd.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 ACON Laboratories, Inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

LIST OF TABLES.

Table 1. North America Infectious Disease Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)

Table 2. US Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3. US Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 4. US Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. US Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 6. US Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 13. Mexico Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 14. Mexico Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Mexico Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Organic Developments Done By Companies

Table 18. Inorganic Developments Done By Companies

Table 19. Glossary of Terms

The List of Companies - North America Infectious Disease Diagnostics Market

● Abbott

● AccuBioTech Co., Ltd.

● ACON Laboratories, Inc.

● BD

● bioMerieux SA

● BIO-RAD LABORATORIES INC.

● Cardinal Health Inc

● Danaher

● F. HOFFMANN-LA ROCHE LTD.

● Trinity Biotech

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America infectious disease diagnostics market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the North America infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the infectious disease diagnostics market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(North America Infectious Disease Diagnostics Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry